Premiere Global Pharmaceutical Consulting Agency Launches


Posted October 26, 2019 by devaughn916

International pharmaceutical consulting agency launches offering former FDA Investigator consultants

 
FD-AID, LLC is announcing the launch of their premier global pharmaceutical consulting firm. The start-up will specialize in a broad spectrum of services which will include sustainable regulatory compliance activities and will also offer "Executive Assistance" in managing their organizations. The company plans to further distinguish itself from other consulting companies through their staffing, composed of former FDA Investigators as well as industry Quality executives. Their service structures will include phone consultation as well as on-site training options such as regulatory readiness/inspection preparedness. Their Executive Assistance service will offer one-on-one coaching with managers who may need an advocate in the background for direction or counseling to get through particularly challenging events.

The firm's founder and president, D.E. Edwards, stated "The services FD-AID provide are distinctive because we have, collectively, experienced every imaginable situation ranging from writing effective FDA-483 responses to consent decree remediation. We also know the day-to-day challenges and emotional support needs that come with managing pharmaceutical operations. We bring technical as well as soft skill expertise." He further commented, "I've had a career as an FDA Investigator as well as several industry executive roles so I have a unique understanding of the needs of both sides."

FD-AID can be contacted through their website: www.fdaid.org or by email at [email protected]

Media Contact

FDAID, LLC
[email protected]
1 7328957831
5514 Garden Arbor Drive
http://fdaid.org
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By FD-AID, LLC
Phone 7328957831
Business Address 5514 Garden Arbor Drive
Lutz, FL
Country United States
Categories Government , Health , Manufacturing
Tags 483 , biological , drugs , fda , food and drug , medical device , pharmaceutical , warning letter
Last Updated October 26, 2019